LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 131 pages found matching glaxo- Avandia Maker Cited by the FDA
Apr-15-08 Washington, DC In what appears to be an epidemic amongst drug manufacturers, the US Food and Drug Administration (FDA) has taken Avandia maker GlaxoSmithKline to task for withholding information about the drug long suspected of harboring a higher risk of heart attack than patients on other diabetes drugs. A stern warning letter was forwarded to Glax... - New Study Praising Avandia Called Insignificant
Apr-10-08 Los Angeles, CA When a drug is vilified as much as diabetes drug Avandia has for the risk of heart attack , one could understand the zeal with which a manufacturer approaches any piece of seemingly good news. This most recent carrot came in the form of a small study, which appears to suggest that Avandia can slow the progression of atherosclerosis in di... - Sheldon Bradshaw - Bush Administration Preemption Gang
Mar-4-08 Washington, DC: Sheldon Bradshaw stepped in to replace the pharmaceutical industry's inside guy, Daniel Troy, in the Office of Chief Counsel at the FDA in April 2005, and the Bush Administration's steadfast protection of the industry did not miss a beat. On September 20, 2005, an article by Lily Henning entitled, "Is FDA's New Chief Counsel a Change in... - Daniel Troy - Bush Administration's Preemption Gang - Part I
Feb-25-08 Washington, DC: Judging by the line-up of current and former Bush Administration attorneys representing the pharmaceutical industry against private citizens in courts all over the country, no conflict-of-interest regulations apply to attorneys who work for Bush. The self-identified primary author of the preemption language in the new drug labeling rul... - Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part II)
Feb-13-08 Washington, DC Apparently, GlaxoSmithKline is still trying to hide damaging information about Paxil, because 9 pages of a report released from under a court order last month, are not available to the public. However, Senator Charles Grassley has instructed Glaxo to provide him with the full report by February 14, 2008. In the report, which is dated roug... - Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part I)
Feb-12-08 Washington, DC GlaxoSmithKline recently received greetings from a Congressional Committee, asking the company to explain the findings in a report unsealed last month in a lawsuit which shows that Glaxo knew as early as 1989 that Paxil increased the risk of suicidal behavior in patients by more than 8-fold compared to patients who received a placebo. In... - Zantac Patent, GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute
New York, NY: (Jan-28-08) Drug developer Cypress Pharmaceutical Inc. had been locked in a patent infringement lawsuit with a unit of British drug maker GlaxoSmithKline PLC related to a generic version of Glaxo's Zantac syrup to treat symptoms of heartburn. Sources close to the case stated that privately held Cypress Pharma said Glaxo agreed not to assert i... - Jury Trials in 2008 Expected to Expose SSRI Maker's Dirty Secrets
Jan-23-08 Washington, DC: The blockbuster sales figures for the new generation of selective serotonin reuptake inhibitor antidepressants ( SSRI 's), which have resulted from their promotion for so many unapproved uses, represents the most profitable off-label marketing coup in the history of modern medicine. Sales total about $21 billion a year, according to IMS Hea... - Preemption - Bush Administration Backs Medtronic in Supreme Court - Part I
Jan-1-08 Washington, DC: Under the arguments made before the US Supreme Court on December 4, 2007, by Deputy Solicitor General Edwin Kneedler, on behalf of the Bush Administration, in support of the medical device maker Medtronic, American citizens injured by a defective device would not be allowed to sue the manufacturer of a product, ever. In a nutshell, the g... - Lawmakers Warn Drug Makers To Knock It Off After Avandia Debacle - Part II
Nov-22-07 Washington, DC: On November 14, 2007, the FDA added a new black box warning to GlaxoSmithKline's diabetes drug Avandia , about a potential increased risk of heart attacks, in addition to the black box warning that was added in August 2007, about the increased risk of heart failure. The FDA said the new warning would also apply to Glaxo's diabetes drugs... - Avandia Maker Tried to Silence Critic, Feds Allege
Nov-19-07 Washington, DC A noted physician who has been warning about the dangerous side effects of Avandia since 1999, and who was the target of alleged intimidation by Avandia manufacturer GlaxoSmithKline (Glaxo) (GSK), was vindicated Thursday by the US Senate Finance Committee. Operating within its jurisdiction over Medicare and Medicaid, the government comm... - Avandia: A New Black Box Warning, and a Reprieve from the FDA
Nov-18-07 Washington, DC As some had predicted, GlaxoSmithKline caved to sustained pressure by the US Food and Drug Administration (FDA) and agreed to add a second black box warning for Avandia , the diabetes drug linked to increased risk of heart attack. However, the warning is somewhat watered-down, and in the absence of any unforeseen, blockbuster medical r... - What will be the Heir to Avandia's Troubled Throne?
Nov-14-07 Washington, DC: While Avandia has proven to be a drag on public relations, and the bottom line for GlaxoSmithKline (GSK), the troubled diabetic drug's propensity for causing heart attack and weight gain is not causing the British drug manufacturer any undue hardship. In fact, third-quarter (Q3) results released November 6th by Chief Financial Office... - World Experts Demand End to Child Drugging in the US - Part II
Oct-27-07 Washington, DC: Mathy Milling Downing was a featured speaker at the annual conference of the International Center for the Study of Psychiatry and Psychology and told the audience that her anger is directed toward the FDA and drug companies, "for their incompetence and lack of concern for innocent children they have helped to kill, my little girl included."... - World Experts Demand End to Child Drugging in the US - Part I
Oct-25-07 Washington, DC: On October 12, 2007, experts in the field of psychiatry and child development from all over the world arrived in Washington to attend the annual conference of the International Center for the Study of Psychiatry and Psychology. This year's conference focused on one specific goal - to end the mass-prescribing of psychiatric drugs to children... - Attorney Subpoenas J&J AstraZeneca and Lilly for Hidden Antipsychotic Data Part II
Sep-10-07 Washington, DC Attorney Jim Gottstein is the director of the Law Project for Psychiatric Rights, a public interest law firm that has mounted a campaign against forced psychiatric drugging all over the country. He represents mostly indigent clients through his non-profit organization and is not involved in the lawsuits filed against the atypical makers by p... - Psychotropic Drug Makers Bankroll Prescribing Shrinks Part I
Aug-30-07 Washington, DC: On August 21, 2007, the Associated Press reported that drug companies spend a lot of money on the members of Minnesota advisory panels who help select the drugs which are to be used by patients covered by Medicaid. The news agency's review of financial disclosure records in Minnesota found that a doctor and a pharmacist on the 8-member p... - FDA now flooded with reports of Heart Failures linked to Avandia
Aug-15-07 Washington, DC The Food and Drug Administration (FDA) has been bombarded with reports of heart attacks, heart failure, and heart-related hospitalizations in diabetics taking Avandia since May 21, the day the New England Journal of Medicine published Dr. Steven Nissen's startling analysis of the drug on the Internet. "The Associated Press obtained t... - Avandia's heart attack risk: are any of the experts "clean"?
Aug-13-07 Los Angeles, CA The diabetes drug Avandia , made by GlaxoSmithKline, hit the news with a bang Jun 14, 2007, when the influential New England Journal of Medicine published a study by heart expert Dr. Steven E. Nissen showing that patients taking the drug had a 43% increase in heart attack risk. This worrying news caught the FDA, diabetics and doctors... - Avandia Drug Maker Accused of Bullying Critics
Aug-9-07 Washington, DC An FDA Committee recently heard testimony from several scientists that suggests that early critics of the diabetes drug Avandia were intimidated by drug maker GlaxoSmithKline. Congressional investigators are examining what they call "very serious" claims that Glaxo "silenced one or more medical professionals who attempted to speak out...